Heterogeneity of uroplakin localization in human normal urothelium, papilloma and papillary carcinoma

1. Ploeg M, Aben KKH, Kiemeney LA. The present and future burden of urinary bladder cancer in the world. World J Urol 2009; 27: 289-93.10.1007/s00345-009-0383-3Search in Google Scholar

2. Eble JN, Sauter G, Epstein J, Sesterhenn IA. World Health OrganizationClassification of Tumours: Tumours of the Urinary System and Male GenitalOrgans. Lyon: IARC Press; 2004.Search in Google Scholar

3. Fležar MS. Urine and bladder washing cytology for detection of urothelial carcinoma: standard test with new possibilities. Radiol Oncol 2010; 44: 207-14.10.2478/v10019-010-0042-8Search in Google Scholar

4. Shen Z, Shen T, Wientjes MG, O´Donnell MA, Au JL-S. Intravesical treatments of bladder cancer: Review. Pharm Res 2008; 25: 1500-10.10.1007/s11095-008-9566-7Search in Google Scholar

5. Schenk-Braat EA, Bangma CH. Immunotherapy for superficial bladder cancer. Cancer Immunol Immunother 2005; 54: 414-23.10.1007/s00262-004-0621-xSearch in Google Scholar

6. Wu XR, Manabe M, Yu J, Sun TT. Large scale purification and immunolocalisation of bovine uroplakins I, II, and III. Molecular markers of urothelial differentiation. J Biol Chem 1990; 265: 1775-84.Search in Google Scholar

7. Wu XR, Lin JH, Walz T, Häner M, Yu J, Aebi U, et al. Mammalian uroplakins. A group of highly conserved urothelial differention-related membrane proteins. J Biol Chem 1994; 269: 13716-24.10.1016/S0021-9258(17)36889-8Search in Google Scholar

8. Sun TT, Liang FX, Wu XR. Uroplakins as markers of urothelial differentiation. Adv Exp Med Biol 1999; 462: 7-18; discussion 103-14.10.1007/978-1-4615-4737-2_110599409Search in Google Scholar

9. Romih R, Veranic P, Jezernik K. Appraisal of differentiation markers in urothelial cells. Appl. Immunohistochem. Mol Morphol 2002; 10: 339-43.Search in Google Scholar

10. Wu R-L, Osman I, Wu X-R, Lu M-L, Zhang Z-F, Liang F-X, et al. Uroplakin II Gene Is Expressed in Transitional Cell Carcinoma But Not in Bilharzial Bladder Squamous Cell Carcinoma: Alternative Pathways of Bladder Epithelial Differentiation and Tumor Formation. Cancer Res 1998; 58: 1291-7.Search in Google Scholar

11. Ogawa K, St John M, Luiza de Oliveira M, Arnold L, Shirai T, Sun TT, et al. Comparison of uroplakin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats and mice. ToxicolPathol 1999; 27: 645-51.10.1177/01926233990270060610588545Search in Google Scholar

12. Romih R, Korošec P, Jezernik K, Sedmak B, Tršinar B, Deng F-M, et al. Inverse expression of uroplakins and inducible nitric oxide synthase in the urothelium of patients with bladder outlet obstruction. BJU Int 2003; 91: 507-12.10.1046/j.1464-410X.2003.03052.x12656904Search in Google Scholar

13. Huang HY, Shariat SF, Sun TT, Lepor H, Shapiro E, Hsieh JT, et al. Persistent uroplakin expressin in advanced urothelial carcinomas: implications in urothelial tumors progression and clinical outcome. Hum Pathol 2007; 38: 1703-13.10.1016/j.humpath.2007.04.003277883617707461Search in Google Scholar

14. Zupančič D, Ovčak Z, Vidmar G, Romih R. Altered expression of UPIa, UPIb, UPII, and UPIIIa during urothelial carcinogenesis induced by N-butyl-N-(4- hydroxybutyl)nitrosamine in rats. Virchows Arch 2011; 458: 603-13.10.1007/s00428-011-1045-621301865Search in Google Scholar

15. Hicks RM, Ketterer B. Hexagonal lattice of subunits in the thick luminal membrane of the rat urinary bladder. Nature 1969; 224: 1304-5.10.1038/2241304a04188048Search in Google Scholar

16. Koss LG. The asymmetric unit membranes of the epithelium of the urinary bladder of the rat. An electron microscopic study of a mechanism of epithelial maturation and function. Lab Invest 1969; 21: 154-68.Search in Google Scholar

17. Hudoklin S, Jezernik K, Neumüller J, Pavelka M, Romih R. Urothelial plaque formation in post-Golgi compartments. PLoS One 2011; 6(8): e23636.10.1371/journal.pone.0023636316105921887288Search in Google Scholar

18. Hudoklin S, Jezernik K, Neumüller J, Pavelka M, Romih R. Electron tomography of fusiform vesicles and their organization in urothelial cells. PLoS One 2012; 7(3): e32935.10.1371/journal.pone.0032935329971622427911Search in Google Scholar

19. Zupančič D, Zakrajšek M, Zhou G, Romih R. Expression and localization of four uroplakins in urothelial preneoplastic lesions. Histochem Cell Biol 2011; 136: 491-500.10.1007/s00418-011-0857-421853341Search in Google Scholar

20. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/ International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J SurgPathol 1998; 22: 1435-48.10.1097/00000478-199812000-000019850170Search in Google Scholar

21. Romih R, Korosec P, Sedmak B, Jezernik K. Mitochondrial localization of nitric oxide synthase in partially differentiated urothelial cells of urinary bladder lesions. Appl Immunohistochem Mol Morphol 2008; 16: 239-45.10.1097/PAI.0b013e31812e513d18301246Search in Google Scholar